As drug candidates discovered via AI move into later-stage clinical trials, the technology seems to be doing as promised: ...

The future of clinical research depends on people just as much as strong systems and processes. Learn what makes great ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

Bari Kowal, Senior Vice President, Development Operations & Portfolio Management at Regeneron Clinical trial innovation is a hot topic, but it’s not a new one. The first fully virtual randomized trial ...

Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical trials by the end ...

The integration of Oracle Argus enables QPS to better capture, manage, and report adverse events for regulatory requirements.

The U.S. Food and Drug Administration (FDA) issued this week three guidance documents related to clinical trials: a draft guidance on multiregional trials in oncology, a draft guidance on integrating ...

The world of medicine has taken a significant leap forward with the first AI-generated drug entering clinical trials. This breakthrough has the potential to revolutionize drug discovery, transforming ...

The FDA’s new draft guidance on Bayesian methodology signals a shift toward more flexible, data-driven clinical trial designs, enabling sponsors to use prior data and adaptive approaches to improve ...

The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...

BOSTON--(BUSINESS WIRE)--Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel ...

Many clinical trials include a placebo group—participants who receive an inactive treatment—so researchers can compare ...